Invited Faculty /Speakers Dirk Hellwig Hospital,Wien Rudolfstiftung Thomas Gruenberger Klinikum Bogenhausen,München Gabriel Glockzin Dresden University HospitalCarlGustav Carus Gunnar Folprecht University HospitalRegensburg Stefan Fichtner-Feigl Bordeaux University ofBordeaux Segalen Serge Evrard Oslo University Hospital Bjørn Edwin dei Tumori, Milan Fondanzione IRCCS Instituto Nazionale Marcello Deraco Papa Giovanni XXIIIHospital,Bergamo Federico Coccolini Université Paris Sud,Villejuif AP-HP HôpitalPaul Brousse Rene Adam Asklepios Hospital Barmbek, Hamburg Asklepios HospitalBarmbek, Karl-J. Oldhafer Aachen Uniklinik RWTH Ulf Peter University HospitalTuebingen Silvio Nadalin Sana Klinikum Offenbach GmbH Dietmar Lorenz University HospitalRegensburg Sven Lang A. University MedicalCenter Mainz Hauke Lang University HospitalTuebingen Igmar Königsrainer University HospitalBonn Jörg Kalff University HospitalRegensburg Matthias Hornung University HospitalRegensburg
Neumann Milano Humanitas Research Hospital,IRCCS, &GeneralSurgery,of Hepatobiliary Director oftheDivision of Surgery Medicine ChairmanoftheDepartment Humanitas University, Schoolof Guido Torzilli University HospitalRegensburg Andreas Teufel Heidelberg University Hospital Ignazio Tarantino Washington CancerInstitute Paul Sugarbaker Ulm University MedicalCenter Thomas Seufferlein University HospitalRegensburg Hans JürgenSchlitt SchmidtKlinikenHorst Wiesbaden Joachim Schirren Klinikum Herne Marc AndreReymond Charité Berlin,Campus Mitte Beate Rau Institut duCancerdeMontpellier Francois Quenet Regensburg Brueder Hospital Barmherzige Pompiliu Piso University HospitalofWürzburg Jörg Pelz General Hospital Medical University Vienna- Christoph Zielinski University MedicalCenter Utrecht Victor J.Verwaal University ofAmsterdam Academic MedicalCenter of Thomas van Gulik Ziekenhuis Oost-Limburg,Genk vanKurt derSpeeten 5.000 € Sponsoring performance forboothfeeandadvertisingpurposes. We thankallsponsors oftheconferencefortheirkindsupport. Both days Congress Fee www.abdominal-metastatic-cancer2016.de Information andregistration [email protected] F: +49941 944-4233 T: +49941 944-4230 93053 Regensburg, Germany Franz-Josef-Strauß-Allee 11 Britta Haseneder Referat UK3Kongresse University HospitalRegensburg Congress Management Lecture HallA2,Franz-Josef-Strauss-Allee 11, 93053Regensburg University HospitalRegensburg, Germany Congress Venue Prof. Dr. Sven Lang([email protected]) A. Congress Secretary BrüderRegensburgHospital Barmherzige Dr.Prof. PompiliuPiso University HospitalRegensburg Dr.Prof. HansJ.Schlitt Scientific Leadership General Informations April 2016 April Foto: Dieter Pirner, www.diegotal.de may besubmittedparticipant atany time. without written cancellation the entire fee becharged. will A substitute fee. In case of tooof 50% participation late cancellation or absence The followingprocessing fees workingapply: 8-3 days before the event In case of acancellation the cancellation statement must be inwriting. deduction. Please transfer the invoice amount before the event date. feesconference. are due upon receipt Participation of invoice without yourAll payments registration binding. is must be made prior to the feeyour during the next participation days by email.Once registered yourAfter you successfulregistration receive will aninvoice concerning Registration conditions Friday, July10th Thursday, July9th 2.0 1.0 Sponsors 75 50 00 € 00 € 0 € 0 €
Integra GmbH,SirtexMedicalEurope GmbH Baxter Deutschland GmbH,MerckSeronoGmbH ThermaSolutions Inc GmbH, TakedaPharmaVertriebGmbH &Co.KG,Technomedics, RAND S.r.l.,RochePharmaAG,Sanofi-Aventis Deutschland Aesculap AG,ewimed,Johnson& MedicalGmbH, Covidien DeutschlandGmbH,Roche PharmaAG Kardialgut Gmbh&EightMedicalInternationalB.V.
100 € 150 € 175 €
MENSCHLICH SPITZE METASTATIC CANCER METASTATIC ABDOMINAL 8 of Surgery Department July 7 & 8, 2016 7&8, July Germany Regensburg, Hospital University th INTERNATIONAL ON SYMPOSIUM IN DER MEDIZIN. IN DER BEGEGNUNG.
ukr.de
www.abdominal-metastatic-cancer2016.de Welcome Address Program Program
Dear colleagues, Thursday, July 7th 2016 Friday, July 8th 2016 08:45 Opening Schlitt MDT – decisions to individualized treatment for Peritoneal Metastasis thousands of patients are diagnosed with metastastatic Local therapies in CRLM Chairman: Piso Chairman: Lorenz 09:00 Liver resection of CRLM: what can be achieved by Surgery alone? 09:00 Systemic treatment options Zielinski abdominal cancer every year, either from gastrointestinal Schlitt 09:17 Local treatment options Piso or gynecological malignancies. In the past, this condition 09:17 SIRT in CRLM – chances and limitations Hellwig 09:34 Discussion was considered untreatable. Over the last decades, howe- 09:34 Combination of liver resection with ablation – chances and pitfalls 09:50 Case presentation for Live OP Hornung Evrard ver, this has changed due to a multidisciplinary appro- 09:56 Case 1 – colorectal cancer with TED voting Koenigsrainer 09:51 R1 resection in CRLM: detrimental or still curative? Torzilli 10:07 Case 2 – gastric cancer with TED voting Glockzin ach. Resectability of liver lesions has improved, enabling 10:08 Live OP 10:18 Case 3 – Pseudomyxoma peritonei with TED voting Pelz a complete tumor removal in half of all patients. New 10:30 Coffee Break 10:30 Key note lecture: Increasing resectability for CRLM – techniques have been established, e.g. in-situ liver split- Liver resection – technical aspects Chairman: Lang H how far can we go? Adam 11:15 Coffee Break ting for two-stage resections of bilateral liver metastases. 11:00 Preoperative assessment of liver function before major resections: current standard and future perspectives van Gulik Surgical technique and intraperitoneal Chemotherapy Chairman: Rau Liver resections for metastases have become standard 11:17 Strategies to increase the FLR: 2-stage, PVE and ….? Quenet 11:45 Tips and Tricks (Video) Sugarbaker treatment for colorectal metastases. 11:34 In-situ splitting/ALPPS: end of the surgical food- chain? Lang S 12:15 HIPEC Van der Spaeten 11:51 Laparoscopic liver resection for CRLM: even in major 12:35 PIPAC Raymond hepatectomies? Edwin For peritoneal metastases cytoreductive surgery (visce- 12:50 Discussion and LIVE OP 12:08 Ante-situ/ex-situ and vascular grafts: even in liver resections for ral resection and peritonectomy procedures) along with CRLM? Oldhafer 13:30 Lunch hyperthermic intraperitoneal chemotherapy and syste- 12:25 Final discussion and LIVE OP Effectiveness of CRS + HIPEC - 2016 Chairman: Verwaal mic chemotherapy is now recommended in the German 13:00 Lunch 14:30 Colorectal Cancer Quenet Gastric Cancer Prognosis and Unresectable/very extended disease Chairman: Grünberger 14:55 Coccolini guideline for the treatment of carcinomatosis originating Mesothelioma 14:00 Prognosis after resection of CRLM: What role does 15:15 Deraco from colorectal cancer. In Germany, following the World immunology play? Fichtner-Feigl 15:35 Live-OP and discussion Congress on Peritoneal Surface Malignancies 2012, the 14:17 Unresectable CRLM: what to do with the primary? Tarantino 16:00 Summary 14:34 Converting to resectability: chemotherapy for irresectable 16:30 End of the meeting awareness regarding this treatment strategy has changed liver metastases Seufferlein in the oncologic community. 14:51 Tumor debulking in LM from CRC: Is there any indication? Kalff 15:08 Role of surgery in synchronous peritoneal and hepatic We would like to invite you to discuss all currently avai- metastases from CRC Nadalin lable treatment options and controversial issues in this 15:25 Synchronous liver and lung metastases: simultaneous or sequential resection? Schirren important field of oncology. 15:42 Final discussion and Live OP 16:00 Coffee Break Should you be interested in participating, please con- Pro/Con Chairman: Schlitt tact the Conference Division of the University Hospital 1. Synchronous Liver metastases with asymptomatic primary of Regensburg phone: +49 941 944-4230, 16:30 Surgery: Resection first Lang H e-mail: [email protected]. 16:40 Oncology: Chemotherapy first Folprecht 16:50 Discussion The organizing teams are looking forward to welcoming 2. Metachronous liver metastases in CRC you in Regensburg in July 2016! 17:00 Surgery: Resection first Neumann 17:10 Oncology: Chemotherapy first Teufel Best regards, 17:20 Discussion 17:30 End of the meeting Prof. Dr. Hans J. Schlitt 19:00 Bavarian evening Prof. Dr. Pompiliu Piso Prof. Dr. Sven A. Lang